CD38 and COVID-19: The analysis of the percentage of the CD19+CD38+CD27+ antibody-secreting B cells (ASCs) in the peripheral blood showed that there was no significant difference between COVID-19 patients (8.4%), the HS (4.5%) and the VS (5.4%) (Figure 2C, P>0.05).